Database: VSD Cancer Registry (Latvia): Difference between revisions
m (Update categories.) |
No edit summary |
||
| Line 1: | Line 1: | ||
Go back to [[Latvia]] page | Go back to [[Latvia]] page | ||
<span style="display:none">forresearchers</span> | <span style="display:none">forresearchers</span> | ||
<span style="display:none">latviacountry</span> | |||
'''Type of database:''' [[databaseType::registry]]. | '''Type of database:''' [[databaseType::registry]]. | ||
Revision as of 14:48, 4 December 2025
Go back to Latvia page
Type of database: registry.
Primary purpose: Provide information about cancer incidence and epidemiology.
Sponsor, manager or home institution: Slimību Profilakses un Kontroles Centrs (SPKC).
Type of information: longitudinal. Data dictionary has not been found. Provides information about malignant tumour cases in the oncology patient register, including details on diagnosis, cancer incidence, population-based rates, geographical distribution, age groups, disease stages, first-year mortality, and observed 5-year survival rates.
Available type of information: Number of registered cancer by region, diagnosis, administrative territory, sex, age group, location, and stage at time of diagnosis, causes of death, among other metrics. More information about the variables: click here to learn more.
Source of information: Data collected from hospital data sources, population registries, cause of death databases, and registers for other diseases that contain oncological data.
Data level: patient level.
Available data level: Administrative territory, regional level and national level.
Number of records: unknown.
Date range: 2010 to 2019.
Cancer areas of interest: C00-C97: All cancer types. Click here to learn more
Data access: partially publicly available: click here to access. Data can be downloaded in the formats XLSX; CSV; PX; JSON; XML; HTM and TXT. Data requires a grant proposal to be accessed. Instructions to request data for restricted content: click here to learn more.
Contact information: Click here to learn more.